Inflammatory mediator biosynthesis enzyme

“Inflammatory mediator biosynthesis enzyme” is an umbrella term referring to any enzyme that catalyzes the formation of molecules involved in initiating or regulating inflammation, most notably lipid-derived mediators like prostaglandins and leukotrienes. Key families within this group include cyclooxygenases (COXs) responsible for converting arachidonic acid into prostanoids; lipoxygenases (LOXs) that generate hydroperoxides leading to leukotriene production; phospholipase A₂s that release fatty acid substrates from membrane phospholipids; and various terminal synthases. These enzymes play central roles not only in acute inflammation but also chronic diseases involving dysregulated immune responses. They are well-established therapeutic targets—most famously via NSAIDs inhibiting COXs—but their diversity means that “inflammatory mediator biosynthesis enzyme” does not refer to one unique protein but rather an entire functional class essential for both health and disease processes.

Other names

Enzymes of inflammatory mediator synthesisPro-inflammatory lipid mediator biosynthetic enzymesEicosanoid pathway enzymes

Again depending on the specific enzyme targeted; common mechanisms include: – Inhibition of enzymatic activity to block production of pro-inflammatory lipid mediators such as prostaglandins or leukotrienes. – Shunting metabolic intermediates toward anti-inflammatory/resolution pathways by selective inhibition. – Multi-target inhibition affecting several steps in eicosanoid/lipid mediator biosynthesis simultaneously.